PTI-1

PTI-1

PTI-1
Systematic (IUPAC) name
N,N-diethyl-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)ethanamine
Identifiers
CAS Registry Number
Chemical data
Formula C21H29N3S
Molecular mass 355.54 g/mol

PTI-1 is an Merck.[2][3][4][5]

See also

References

  1. ^ "PTI-1". Cayman Chemical. Retrieved 8 July 2015. 
  2. ^ Julia Adam-Worrall, et al. (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor. Patent US 7700634, priority date 5 March 2004
  3. ^ Paul David Ratcliffe, et al. Indole Derivatives. Patent US 7763732, priority date 24 August 2005
  4. ^ Julia Adam, et al. Indole Derivatives. Patent WO 2008/101995, priority date 22 February 2007
  5. ^ Takao Kiyoi, et al. Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists. Bioorganic and Medicinal Chemistry Letters 2011; 21(6):1748-1753. doi: 10.1016/j.bmcl.2011.01.082